# VTC Seed Fund

> VTC Seed Fund is a VC fund in Roanoke backing Medical, Therapeutics and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Roanoke, United States
- Total investments: 3
- Last investment: Apr 2021
- Lead investor: 33%
- Last updated: Aug 2026
- Website: https://www.vtcseedfund.com/

VTC Seed Fund is an early stage investor.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Therapeutics | 2 | 67% |
| Biotechnology | 2 | 67% |
| Software | 1 | 33% |
| Logistics | 1 | 33% |

9 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SWARM | SWARM is an AI-powered operational optimization company that builds decision intelligence software for agrifood and manufacturing. The company focuses on helping organizations improve efficiency and reduce costs by using AI systems that model operational challenges and generate optimized decisions across areas such as supply chain planning,logistics, workforce allocation, pricing, and production management. Its platform is designed around an agent-based architecture that uses intelligent systems to interpret business data, identify inefficiencies, and recommend or execute improved operational plans. Rather than requiring users to build models or write code, SWARM allows organizations to define operational problems in a structured way and then uses AI-driven engines to compute optimal solutions. | $2.7M | Seed | Apr 15, 2021 |  |
| Slate Bio | Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics. | $1.8M | Seed | Jan 19, 2021 |  |
| Veralox Therapeutics | Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients. | $5.4M | Seed | Sep 05, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [Virginia Venture Partners](https://shizune.co/investors/profile/cit-gap-funds) — VC Fund, 1 deal together
- [Epidarex Capital](https://shizune.co/investors/profile/epidarex-capital) — VC Fund, 1 deal together
- [Harvard Business School Angels Chicago](https://shizune.co/investors/profile/harvard-business-school-angels-chicago) — VC Fund, 1 deal together
- [JDRF T1D Fund](https://shizune.co/investors/profile/jdrf-t1d-fund) — VC Fund, 1 deal together
- [TEDCO](https://shizune.co/investors/profile/maryland-technology-development-corporation) — VC Fund, 1 deal together
- PharmaDirections — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does VTC Seed Fund invest in?

VTC Seed Fund invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did VTC Seed Fund last invest?

The most recent investment recorded for VTC Seed Fund closed in Apr 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co